Transcriptional analyses of antifungal drug resistance in Candida albicans.
about
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida speciesAzole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungiEfflux in fungi: la pièce de résistanceDrug-induced regulation of the MDR1 promoter in Candida albicans.Critical annotations to the use of azole antifungals for plant protectionCalcineurin is essential for survival during membrane stress in Candida albicans.Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis.Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole.Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterolsTranscriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding siteDifferential gene expression in auristatin PHE-treated Cryptococcus neoformansAn MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicansEvolutionary dynamics of Candida albicans during in vitro evolution.Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.Synthesis and chain-dependent antifungal activity of long-chain 2H-azirine-carboxylate esters related to dysidazirine.Resistance mechanisms in clinical isolates of Candida albicansMolecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugsTranscriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicanscis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations.Investigating the role of ABC transporters in multifungicide insensitivity in Phytophthora infestans.Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump.Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.Functional analysis of a vacuolar ABC transporter in wild-type Candida albicans reveals its involvement in virulence.
P2860
Q24549843-48826359-0BD9-407E-A673-881B2F6673A8Q28475655-69D3F6AC-7403-4038-B885-F9EF1D6C4144Q33474798-D2BE843C-35C4-49EF-8A53-E7C2A5A58AB3Q33883805-BB0AE801-096F-45C8-A1B9-11F877E74F00Q33983259-D64DC5CA-26CC-4078-85D3-7BFDFD7663A5Q34085830-E63072EC-D8A7-458E-A394-678D1A4AB44EQ34141180-9ABBC7FF-8061-4193-AF3D-9EF45093E8F3Q34142347-2BBEED41-5AF5-464C-A5FE-32DC474FEFF8Q34510556-3AB197A2-5D5D-49A7-AA8B-859FBF38385DQ34519189-B6B1BB8F-50EA-4701-8232-A42CB80F5C1DQ34887876-158B8CE9-41F3-4F75-8FDC-3AFE4A647515Q35072285-6FCBF284-330D-4197-8792-49455634A281Q35164903-3E7CD5C0-7543-495B-973A-310716C22E32Q35216756-823186D9-A3AA-4004-B565-FCD20AF72E6CQ35547462-27FA2CEB-AA1E-40B4-AC89-840F7BFD4517Q37417553-F464D605-273F-4BD5-B4E1-769BCECB0B3FQ38955748-DC722015-9CBB-4B67-BCCC-42BD7B820526Q39475859-42B85A92-0031-40CB-9D03-3CF8393FF231Q39496765-7FFA347D-889D-42B5-A5C0-826CC806A881Q39652037-E7D2557B-00A8-476A-A898-9D015270CC01Q40231350-D5AC9ADA-40EF-488C-8190-657ECBA1878AQ40706099-305DB99A-EE69-4AA6-A021-CBFDC5AF087EQ41785049-9D6100EA-F83E-4466-9AB0-EAD2242766B9Q42909489-C837B849-2008-427C-9447-DD26CBFE7F35Q43048723-7B6B0DC6-BB83-4AFA-B30E-E16BDB2F8083Q43052654-48808BAF-94F4-4DF1-A5D3-2A4B33E833E6Q44652873-1458CF33-EF4F-430F-8F3B-6859B1A2AD6DQ47329636-C8CA9418-1E40-4320-9672-D8C289C1487DQ48310913-8E8550D7-76F0-4444-99FB-4A1228138841
P2860
Transcriptional analyses of antifungal drug resistance in Candida albicans.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@en
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@nl
type
label
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@en
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@nl
prefLabel
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@en
Transcriptional analyses of antifungal drug resistance in Candida albicans.
@nl
P2860
P1476
Transcriptional analyses of antifungal drug resistance in Candida albicans
@en
P2093
P2860
P304
P356
10.1128/AAC.44.9.2296-2303.2000
P407
P577
2000-09-01T00:00:00Z